Duration of Fever and Intravenous Anti-Infective Therapy in Induction Course 1
| . | Filgrastim . | Placebo . | |
|---|---|---|---|
| Fever (days) | |||
| Median | 7.0 | 8.5 | P = .0096-150 |
| Quartiles | 3.0-13.0 | 5.0-15.0 | |
| Range | 0-38 | 0-38 | |
| Number of patients | 259 | 262 | |
| Intravenous anti-infectives (days) | |||
| Median | 15.0 | 18.5 | P = .00016-150 |
| Quartiles | 10.0-20.0 | 13.0-27.0 | |
| Range | 0-54 | 0-54 | |
| Number of patients | 259 | 262 |
| . | Filgrastim . | Placebo . | |
|---|---|---|---|
| Fever (days) | |||
| Median | 7.0 | 8.5 | P = .0096-150 |
| Quartiles | 3.0-13.0 | 5.0-15.0 | |
| Range | 0-38 | 0-38 | |
| Number of patients | 259 | 262 | |
| Intravenous anti-infectives (days) | |||
| Median | 15.0 | 18.5 | P = .00016-150 |
| Quartiles | 10.0-20.0 | 13.0-27.0 | |
| Range | 0-54 | 0-54 | |
| Number of patients | 259 | 262 |
Durations counted from day 6.
Wilcoxon Rank Sum Test.